Simplifying Global Compliance
Report Outlines Risk Factors for Low Enrollment In Cancer Trials
Clinical Trials Advisor
Roughly a fifth of cancer clinical trials fail to recruit enough participants, creating a “major barrier to progress” for developing new therapies, according to a paper published in the Journal of the National Cancer Institute.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing